Angelo Michilli

Background

About Angelo Michilli

Dr. Angelo Michilli is a Postdoctoral Researcher in Prof. Massimo Negrini’s laboratory at the University of Ferrara, where he contributes to multiple projects in the field of translational oncology. His research is primarily focused on the molecular characterization of human tumors and the application of liquid biopsy approaches for diagnosis, prognosis, treatment stratification, and disease monitoring. Dr. Michilli has developed strong expertise in next-generation sequencing (NGS) technologies, including both Ion Torrent and Illumina platforms, with hands-on experience in library preparation, sequencing, and data analysis. He is also proficient in quantitative molecular techniques such as Real-Time PCR and Droplet Digital PCR (ddPCR), and in the use of bioinformatics tools for the interpretation of sequencing data. His work includes in vitro and in vivo preclinical models, particularly focused on hepatocellular carcinoma. He has extensive experience with murine models, including animal handling, drug administration, tissue collection, and compliance with 3Rs principles. Currently, Dr. Michilli is investigating novel therapeutic strategies to overcome resistance mechanisms to sorafenib, combining pharmacological and molecular biology approaches.